четвъртък, 23 август 2018 г.

Weekly Update: New diabetes clinical trial (18 items)


New diabetes clinical trial: Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

Published on: August 13, 2018 at 07:00PM
Conditions:   Diabetes;   Diabetic Foot;   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1
Interventions:   Device: Cytal Wound Matrix 1-Layer;   Other: Standard of Care (SOC)
Sponsor:   ACell Inc.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03626623?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)

Published on: August 13, 2018 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: SGLT2;   Drug: Metformin
Sponsor:   Brigham and Women's Hospital
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03627039?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes

Published on: August 13, 2018 at 07:00PM
Condition:   Type2 Diabetes
Interventions:   Drug: CKD-501 0.5mg;   Drug: Placebo
Sponsor:   Chong Kun Dang Pharmaceutical
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03627182?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Troponin I and T and Adverse Outcomes in Patients With and Without Diabetes Mellitus After Coronary Intervention

Published on: August 13, 2018 at 07:00PM
Conditions:   Coronary Artery Disease;   Diabetes Mellitus
Intervention:   Other: Percutaneous coronary intervention
Sponsors:   Wilhelminenspital Vienna;   Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology
Completed
https://clinicaltrials.gov/ct2/show/NCT03627455?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Diabetes Treatment in Rural Guatemala

Published on: August 13, 2018 at 07:00PM
Condition:   Diabetes
Interventions:   Other: Primary visit and assessment;   Other: Follow up visits;   Other: 3 month visits;   Other: Unscheduled visits
Sponsors:   University of Wisconsin, Madison;   Stanford University
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03626909?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Multi-component Intervention for Diabetes in Adults With Serious Mental Illness

Published on: August 13, 2018 at 07:00PM
Conditions:   Schizophrenia;   Obesity;   Diabetes;   Lifestyle Risk Reduction;   Serious Mental Illness
Intervention:   Behavioral: Multi-component Intervention for Diabetes in Adults with Serious Mental Illness
Sponsor:   University of California, San Diego
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03627377?term=diabetes&sfpd_d=14 August 13, 2018 at 07:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults

Published on: August 14, 2018 at 07:00PM
Condition:   Obesity or Overweight
Interventions:   Behavioral: ID-DPP group;   Other: Wait-list Group
Sponsor:   Universidad de Sonora
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03629301?term=diabetes&sfpd_d=14 August 14, 2018 at 05:00PM

via ClinicalTrials.gov


New diabetes clinical trial: Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

Published on: August 15, 2018 at 07:00PM
Condition:   Type2 Diabetes
Intervention:   Drug: Basalin to Lantus
Sponsor:   Nanjing First Hospital, Nanjing Medical University
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03631121?term=diabetes&sfpd_d=14 August 15, 2018 at 05:01PM

via ClinicalTrials.gov


New diabetes clinical trial: Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D

Published on: August 15, 2018 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: Liraglutide;   Drug: Golimumab
Sponsors:   Carla Greenbaum, MD;   Juvenile Diabetes Research Foundation
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03632759?term=diabetes&sfpd_d=14 August 15, 2018 at 05:01PM

via ClinicalTrials.gov


New diabetes clinical trial: A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)

Published on: August 15, 2018 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Semaglutide
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03631186?term=diabetes&sfpd_d=14 August 15, 2018 at 05:01PM

via ClinicalTrials.gov


New diabetes clinical trial: Identification and Validation of Noninvasive Biomarkers of the Diagnosis and Severity of NASH in Type 2 Diabetics

Published on: August 16, 2018 at 07:00PM
Condition:   Type2 Diabetes
Interventions:   Device: new quantitative imaging techniques;   Diagnostic Test: blood sample;   Diagnostic Test: second generation tests
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03634098?term=diabetes&sfpd_d=14 August 16, 2018 at 05:01PM

via ClinicalTrials.gov


New diabetes clinical trial: Diabetic Retinopathy and Subclinical Signs of Disease Transition

Published on: August 17, 2018 at 07:00PM
Condition:   Diabetic Retinopathy
Intervention:   Diagnostic Test: Optical Coherence Tomography Angiography
Sponsor:   University of British Columbia
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03635671?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Published on: August 17, 2018 at 07:00PM
Condition:   Bullous Pemphigoid
Intervention:   Drug: data report
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03636763?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Tart Cherry Juice and Markers of Inflammation, CVD, and Diabetes

Published on: August 17, 2018 at 07:00PM
Conditions:   Hyperuricemia;   Insulin Resistance;   Obesity;   CVD
Interventions:   Dietary Supplement: Tart cherry juice;   Other: Placebo
Sponsors:   University of Memphis;   Arizona State University
Completed
https://clinicaltrials.gov/ct2/show/NCT03636529?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Raclopride-PET/MRT

Published on: August 17, 2018 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Other: intranasal insulin;   Other: Placebo
Sponsor:   University Hospital Tuebingen
Recruiting
https://clinicaltrials.gov/ct2/show/NCT03637075?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Cell Therapy for Peripheral Arterial Disease and Diabetes

Published on: August 17, 2018 at 07:00PM
Conditions:   Peripheral Arterial Disease;   Diabetes Mellitus
Intervention:   Procedure: celular therapy
Sponsors:   Hospital Regional de Alta Especialidad del Bajio;   Instituto Mexicano del Seguro Social
Active, not recruiting
https://clinicaltrials.gov/ct2/show/NCT03635970?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery

Published on: August 17, 2018 at 07:00PM
Conditions:   Bariatric Surgery;   Obese;   Type2 Diabetes
Interventions:   Biological: Vasculary biological assessment;   Biological: Analysis of vasomotor endothelial function;   Biological: Analysis of arterial compliance;   Biological: Exploration of microcirculation;   Biological: Venous Doppler Ultrasound;   Biological: Arterial pressure measurement;   Biological: Intima-Media Thickness measurement;   Biological: Exploration of neuropathy;   Behavioral: level of physical activity
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03636243?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


New diabetes clinical trial: Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes

Published on: August 17, 2018 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Intervention:   Drug: Gamma-Aminobutyric Acid (GABA)
Sponsors:   Per-Ola Carlsson;   Diamyd Medical AB
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT03635437?term=diabetes&sfpd_d=14 August 17, 2018 at 05:36PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар